| INTRODUCTION
Robotic surgery for pancreatic cancer is coming of age. Several institutional series have demonstrated that by appropriate patient selection, a team of highly skilled pancreatic surgeons can safely perform a robotic distal pancreatectomy (RDP) with sound oncologic principles. [1] [2] [3] [4] Minimally invasive distal pancreatectomy is increasingly favored in specialty centers because it results in decreased pain, a shorter length of stay, and fewer wound-related complications.
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Recently, we found that the short-term and long-term oncologic outcomes for open and laparoscopic distal pancreatectomy (LDP) for pancreatic cancer are comparable. 8 The robotic platform enables surgeons to overcome some of the technical limitations of conventional laparoscopy. It allows for increased dexterity and depth perception with improved ergonomics. Potentially, the improved precision in surgical dexterity provides several advantages when performing distal pancreatectomy, such as higher spleen preservation rates and less frequent rates of conversion to open resection. 2, 9 Moreover, the precise dissection and enhanced visualization may confer oncologic benefits, such as increased R0 resections and increased number of lymph nodes harvested. 2 Despite these benefits, the significant cost of robotic instrumentation combined with longer operative time makes it difficult to justify the use of the robotic platform in the current healthcare environment as an alternative to the less resource-intensive laparoscopic approach. 10, 11 However, the cost of RDP is likely to decline in the near future due to the anticipated competition from alternative robotic platforms. As the cost of RDP decreases, the comparative effectiveness of the modalities will become increasingly important. 12 Since the data are publicly available upon request, the study was exempt from institutional review board approval.
| Patient selection
Patients diagnosed with pancreatic adenocarcinoma in the body or tail of the pancreas from 2010 to 2013 were identified using Kaplan-Meier curves were used to depict survival differences between the two groups. The log-rank test was used to test these differences for statistical significance. Survival data were not available for patients diagnosed in 2013. Survivors were censored at the date of last contact, whereas those who died were censored at the date of death. All analyses were performed using STATA MP Version 14 (StataCorp, College Station, TX).
| RESULTS
A total of 704 patients, in 268 hospitals, underwent minimally invasive distal pancreatectomy. Of these, 605 (86%) patients, in 251 hospitals, underwent LDP and 99 (14%) patients, in 54 hospitals, underwent RDP.
The baseline characteristics for LDP and RDP are shown in Table 1 . All baseline characteristics were equally distributed across both groups. For hospitals that utilized either technique at least once during the study period, the median number of LDP cases was 1 (range, 1 to 30; 53%, 1 case; 20%, 2 cases; 27%, >2 cases) and that for RDP cases was 1 (range, 1 to 15; 57%, 1 case; 32%, 2 cases; 11%, >2 cases). The distribution of LDP and RDP cases by annual hospital volume of all pancreatic cancer resections is demonstrated in Figure 1 .
The clinicopathologic and treatment characteristics of patients in the two groups are shown in Table 2 . There were no statistical differences in the clinicopathologic characteristics between LDP and RDP.
The median follow-up was 25 months. There were no differences in the two groups with respect to the oncologic outcomes, as summarized in Table 3 . The conversion rate was significantly higher for the laparoscopic approach. Kaplan-Meier survival estimates of patients in the LDP and RDP group were not statistically different ( Figure 2 ).
Since early years may represent surgeons in the learning curve of robotic surgery , we analyzed differences in the outcomes of the robotic cohort over time. We found that the number of robotic and laparoscopic distal pancreatic resections per year increased over time ( Figure S1 ). On univariate analysis, we found a statistically significant decrease in length of stay with robotic resections over time (Table S1 ). There was no difference in the number of nodes examined, the rate of positive margin resection, conversion to open approach, readmissions, or mortality. However, the 1-year overall survival increased over time.
| DISCUSSION
Despite cost constraints and the lack of evidence for oncologic benefits, the national experience with the adoption of the robotic platform for pancreatic cancer resections is increasing. The current study evaluated the comparative effectiveness of RDP versus LDP for short-and long-term oncologic outcomes. In addition, we also analyzed post-operative outcomes in this study.
In terms of oncologic outcomes, there are several findings that merit discussion. This is the first study that specifically compares long-term overall survival after minimally invasive distal pancreatectomy between the two modalities. The median follow-up of the cohort was sufficient to reach the median survival after pancreatic adenocarcinoma resection (~25 months).
The study failed to demonstrate a difference in the overall survival between the two groups. Given the lack of data on overall survival after RDP for pancreatic cancer in the literature, these findings are important.
Similarly, there were no differences in the short-term oncologic outcomes, such as lymph nodes examined, margin-positive rate, and time to adjuvant chemotherapy between the two groups. These findings contradict one study that demonstrated the superiority of RDP over LDP with respect to lymph node retrieval and the ability to achieve margin-negative resections, which could be attributed to a type 1 statistical error. The study found that conversion rates were significantly lower with RDP compared with LDP. This has been observed in previous institutional reports comparing the two approaches. (assuming that expertise in the laparoscopic skillset improved operative performance on the robotic platform). 15 Although we do not have comparative data on individual surgeon experience or the institutional experience with the minimally invasive approach, we note that the two groups were similar with respect to the overall volume of pancreatic cancer resections. Given these limitations, the reduced conversion rate observed in this study should be interpreted with caution.
The trend toward implementing new technology for a complex operation, such as distal pancreatectomy, in low-volume centers could be considered worrisome. 16 The majority of hospitals included in this study only performed one RDP (57%) and one LDP (53%) for pancreatic cancer during the study period encompassing 4 years.
Furthermore, approximately 75% of the hospitals performing each of these operations could be considered low volume for any pancreatic resection for cancer. These results are comparable to national trends. beyond the scope of this study. However, the low mortality with either approach suggests that patients in both groups were highly selected. Abbreviation: IQR, interquartile ranges.
T A B L E 2 Laparoscopic versus robotic distal pancreatectomy-clinicopathologic and treatment characteristics
The findings of the study should be interpreted with caution, given its retrospective design. Although the baseline characteristics were comparable between the two groups, not all factors are accounted for. For instance, there was no information on surgeon experience in the database that could impact outcomes. However, the groups were compared on many factors that determine oncologic and postoperative outcomes. Second, although the oncologic outcomes are similar between the two groups, the study was not powered to conclude on the noninferiority of survival, which would require a much larger sample size. 23 However, in the near future, several other companies are expected to bring their surgical robotic system on the market. Hence, the costs are expected to decrease significantly. The decision to perform RDP over LDP, therefore, will ultimately depend on the comparative effectiveness of the two modalities and the surgeon's skill set.
In conclusion, this nationwide retrospective study found similar short-term and long-term oncologic outcomes between highly selected, well-balanced RDP, and LDP cohorts. Similarly, postoperative outcomes were comparable for the two approaches, with a potentially lower conversion rate for the robotic approach.
Considering the limitations of a retrospective design, future prospective studies should further investigate the clinical benefit of the use of a robotic system compared with conventional laparoscopy in distal pancreatic resections.
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